Gene · 11255
Papers1,482
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,482
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of heterodimers formed by histamine H3 receptors and dopamine D1 receptors on the methamphetamine-induced conditioned place preference. | Eur J Pharmacol | 2024 | 39089461 | PubTator, text mining | PubMed |
| Carotid body plastic behavior: evidence for D2-H3 receptor-receptor interactions. | Front Physiol | 2024 | 39072219 | PubTator, text mining | PubMed |
| The story of clobenpropit and CXCR4: can be an effective drug in cancer and autoimmune diseases? | Front Pharmacol | 2024 | 39070795 | PubTator, text mining | PubMed |
| Putative Pharmacological Depression and Anxiety-Related Targets of Calcitriol Explored by Network Pharmacology and Molecular Docking. | Pharmaceuticals (Basel) | 2024 | 39065743 | PubTator, text mining | PubMed |
| Targeting Microglia in Neuroinflammation: H3 Receptor Antagonists as a Novel Therapeutic Approach for Alzheimer's Disease, Parkinson's Disease, and Autism Spectrum Disorder. | Pharmaceuticals (Basel) | 2024 | 39065682 | PubTator, text mining | PubMed |
| Histamine H3 Receptor Isoforms: Insights from Alternative Splicing to Functional Complexity. | Biomolecules | 2024 | 39062475 | PubTator, text mining | PubMed |
| Reproductive and fetal toxicity studies of histamine H3 receptor antagonist DL76 used in mice to prevent maximal electroshock-induced seizure. | Front Pharmacol | 2024 | 38903994 | PubTator, text mining | PubMed |
| Chemogenetic activation of histamine neurons promotes retrieval of apparently lost memories. | Mol Brain | 2024 | 38877480 | PubTator, text mining | PubMed |
| Synthesis and Pharmacological Characterization of New Photocaged Agonists for Histamine H3 and H4 Receptors. | Pharmaceuticals (Basel) | 2024 | 38675496 | PubTator, text mining | PubMed |
| Molecular Determinant Underlying Selective Coupling of Primary G-Protein by Class A GPCRs. | Adv Sci (Weinh) | 2024 | 38647423 | PubTator, text mining | PubMed |
| Therapeutic potential of LINS01 histamine H3 receptor antagonists as antineoplastic agents for triple negative breast cancer. | Biomed Pharmacother | 2024 | 38579399 | PubTator, text mining | PubMed |
| 4-Oxypiperidine Ethers as Multiple Targeting Ligands at Histamine H3 Receptors and Cholinesterases. | ACS Chem Neurosci | 2024 | 38440987 | PubTator, text mining | PubMed |
| Discovery of Novel Steroid-Based Histamine H3 Receptor Antagonists/Inverse Agonists. | J Med Chem | 2024 | 38393759 | PubTator, text mining | PubMed |
| Pharmacological characterization of seven human histamine H3 receptor isoforms. | Eur J Pharmacol | 2024 | 38387718 | PubTator, text mining | PubMed |
| Histamine-3 Receptor Availability and Glutamate Levels in the Brain: A PET-1H-MRS Study of Patients With Schizophrenia and Healthy Controls. | Int J Neuropsychopharmacol | 2024 | 38373256 | PubTator, text mining | PubMed |
| A virtual library of small molecules mimicking dipeptides. | Arch Pharm (Weinheim) | 2024 | 38332463 | PubTator, text mining | PubMed |
| Targeting Alzheimer's Disease: Evaluating the Efficacy of C-1 Functionalized N-Aryl-Tetrahydroisoquinolines as Cholinergic Enzyme Inhibitors and Promising Therapeutic Candidates. | Int J Mol Sci | 2024 | 38256107 | PubTator, text mining | PubMed |
| Novel Pitolisant-Derived Sulfonyl Compounds for Alzheimer Disease. | Int J Mol Sci | 2024 | 38255872 | PubTator, text mining | PubMed |
| First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer's Disease. | J Med Chem | 2024 | 38190615 | PubTator, text mining | PubMed |
| Preliminary studies of 1,5-benzoxazepine derivatives as potential histamine H3 receptor antagonists. | Future Med Chem | 2024 | 38189171 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11255/papers?page=5